Phlexglobal Announces Rick Riegel as Chief Executive Officer

AMERSHAM, England & MALVERN, Pa.--()--Phlexglobal, the specialist provider of innovative Trial Master File (TMF) and electronic Trial Master File (eTMF) expertise, solutions and services to the life sciences industry today announced the appointment of Richard (Rick) Riegel as Chief Executive Officer and as a new member of its Board of Directors. Rick will be based in Phlexglobal’s US headquarters in Malvern, Pennsylvania.

Rick brings to Phlexglobal 30 years of executive leadership and sales experience with technology and professional services firms focused on meeting the needs of companies in the pharmaceutical and life sciences industries including IBM, First Consulting Group, and Taratec Development. Most recently Rick was CEO of LIQUENT, a software technology and outsourcing services organization specialized in providing solutions that meet life sciences clients’ needs across their regulated business processes that support product development, approval, and lifecycle. During his tenure, Rick oversaw LIQUENT’s transformation from a point publishing software solution supplier into the leading provider of Regulatory Information Management solutions to the life sciences industry. These solutions included the market leading LIQUENT InSight software platform and a broad range of Regulatory outsourcing services.

“I am privileged to be joining such a talented and successful team whose dedication and focus to client success and industry thought leadership has made Phlexglobal the leading provider of trial master file services and technology solutions in the industry,” said Rick. “I look forward to what we can do together, and with our customers, to build on our results to date. In the future, successful solution providers will be the companies that can provide the most productive, compliant and cost effective services and technology solutions and Phlexglobal is uniquely positioned to be the leader.”

"Rick has a strong understanding of the life sciences clinical and regulatory space and the unique demands of leading companies that provide both technology and outsourcing services solutions,” said Steven Kent, Chairman of the Board of Phlexglobal. "This, combined with his successful track record leading global solution providers to the industry, makes him the perfect fit for Phlexglobal, especially as we continue to innovate and grow, both organically and through acquisition, as an independent, privately held company."

Adds Stella Donoghue, Phlexglobal’s Managing Director, "Rick’s experience and leadership will be invaluable to our existing team, and I know that Phlexglobal and our clients are going to benefit greatly from his years of providing solutions to the life sciences industry. He has a true commitment to client success, building a strong team and organization, and making a lasting impact on the industry. Our management team and I look forward to working with Rick to continue to grow our position in the industry."

About Phlexglobal

Phlexglobal is a specialist provider of technology-enabled, Trial Master File (TMF & eTMF) document management solutions and other support services. They offer a unique combination of clinical trial knowledge, document management skills, regulatory understanding and technical expertise to deliver a range of flexible, targeted solutions to meet business needs.

More information can be found at http://www.phlexglobal.com

-Ends-

Contacts

Phlexglobal Ltd
Gillian Gittens
Tel: +44(0)1494 720420
Email: info@phlexglobal.com

Release Summary

Phlexglobal, the specialist provider of innovative TMF and eTMF expertise, solutions & services, today announced the appointment of Richard Riegel as CEO & as a new member of its Board of Directors.

Contacts

Phlexglobal Ltd
Gillian Gittens
Tel: +44(0)1494 720420
Email: info@phlexglobal.com